α1-Blockers for BPH: Are There Differences?
α 1 -blockers are well established for the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO), previously referred to as benign prostatic hyperplasia (BPH). The various available α 1 -blockers do not differ in terms of their clinical efficacy, but there...
Gespeichert in:
Veröffentlicht in: | European urology 1999, Vol.36 (Suppl 3), p.52-63 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!